Feasibility of sequential adjuvant chemotherapy with a 3-month oxaliplatin-based regimen followed by 3 months of capecitabine in patients with stage III and high-risk stage II colorectal cancer: JSWOG-C2 study

BACKGROUND: Six months of oxaliplatin-based chemotherapy is the standard adjuvant chemotherapy for completely resected stage III colorectal cancer (CRC). Also, patients with stage II CRC who are considered to be at high risk of disease recurrence often receive the same adjuvant chemotherapy treatmen...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Drug Des Devel Ther
Main Authors: Tsuruta, Atsushi, Yamashita, Kazuki, Tanioka, Hiroaki, Tsuji, Akihito, Inukai, Michio, Yamakawa, Toshiki, Yamatsuji, Tomoki, Yoshimitsu, Masanori, Toyota, Kazuhiro, Yamano, Taketoshi, Nagasaka, Takeshi, Okajima, Masazumi
פורמט: Artigo
שפה:Inglês
יצא לאור: Dove Medical Press 2016
נושאים:
Original Research
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC5125792/
https://ncbi.nlm.nih.gov/pubmed/27920498
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S112322
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים